Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.

BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	BioMed Central 2011

Παρόμοια τεκμήρια

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
ανά: Lindegardh Niklas, κ.ά.
Έκδοση: (2011-07-01)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
ανά: Jamsen, K, κ.ά.
Έκδοση: (2012)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
ανά: Jamsen Kris M, κ.ά.
Έκδοση: (2012-07-01)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
ανά: Luxemburger, C, κ.ά.
Έκδοση: (1995)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2006)

Towards optimal design of anti-malarial pharmacokinetic studies.
ανά: Simpson, J, κ.ά.
Έκδοση: (2009)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2013)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
ανά: Nosten, F
Έκδοση: (2010)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2009)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
ανά: Hoglund, R, κ.ά.
Έκδοση: (2012)

Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria.
ανά: Price, R, κ.ά.
Έκδοση: (1998)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Uganda
ανά: Tarning Joel, κ.ά.
Έκδοση: (2012-08-01)

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2014)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
ανά: McGready, R, κ.ά.
Έκδοση: (2009)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated <it>Plasmodium falciparum </it>malaria
ανά: Quezada Wilmer, κ.ά.
Έκδοση: (2009-04-01)

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
ανά: Valea, I, κ.ά.
Έκδοση: (2014)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria.
ανά: Bethell, D, κ.ά.
Έκδοση: (1997)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
ανά: Price, R, κ.ά.
Έκδοση: (1999)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial
ανά: Birgersson, S, κ.ά.
Έκδοση: (2019)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
ανά: Hoglund Richard M, κ.ά.
Έκδοση: (2012-11-01)

The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
ανά: Newton, P, κ.ά.
Έκδοση: (2006)

Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
ανά: Monia Guidi, κ.ά.
Έκδοση: (2019-04-01)

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
ανά: van Vugt, M, κ.ά.
Έκδοση: (2002)

Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin
ανά: Michelle V. D. Ferreira, κ.ά.
Έκδοση: (2018-07-01)

Towards optimal design of anti-malarial pharmacokinetic studies
ανά: White Nicholas J, κ.ά.
Έκδοση: (2009-08-01)

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2015)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2006)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
ανά: Oméga Raobela, κ.ά.
Έκδοση: (2018-08-01)